
Although its organizational infrastructure is virtual, the Community Pharmacy Foundation (CPF) is ‘anything but’ and is quite quantifiable and impactful in its vision, mission, and deliverables.

Although its organizational infrastructure is virtual, the Community Pharmacy Foundation (CPF) is ‘anything but’ and is quite quantifiable and impactful in its vision, mission, and deliverables.


ASHP has selected Sophia R. Chhay as its 2017-2018 Executive Fellow in Association Leadership and Management.

FDA officials today announced the approval of Emflaza (deflazacort) tablets and oral suspension for the treatment of Duchenne muscular dystrophy (DMD).

According to the National Institute for Occupational Safety and Health (NIOSH), an estimated 8 million health care workers in the United States are exposed to hazardous drugs (HDs) each year.

Three Veterans Affairs pharmacy employees are facing charges related to a conspiracy to steal and distribute prescription pills.

Regeneca Worldwide, a California dietary supplement distributor, has been ordered to stop selling their products, FDA officials announced today.

The Walgreens Flu Index is a weekly report developed to provide state- and market-specific information regarding flu activity, and ranking of those experiencing the highest incidences of influenza across the country.

CVS Health Corporation has announced operating results for the three months and year ended December 31, 2016.

An Illinois House bill is looking to reduce prescription drug errors in pharmacies by introducing legislation that eases some of the pressures of working in a pharmacy.

Make it a business trip and add get some CE then tack on some extra days with the family in a spot like sunny Orlando, Florida.

Over the years, a number of landmark clinical studies on asthma have been published, shaping how we treat the disease today.

The HIPAA Privacy Rule, effective on April 14, 2003, regulates the use and disclosure of protected health information (PHI) by covered entities.

Proposals such as allowing Medicare price negotiation, capping out-of-pocket drug costs, importing drugs, and limiting manufacturer’ spending on patient marketing could all result in lower HCV drug costs.

The FDA has greenlighted Amgen’s Parsabiv (etelcalcetide) as the first therapy in 12 years approved to treat secondary hyperparathyroidism (HPT) in adult patients with chronic kidney disease (CKD) on hemodialysis.

Eli Lilly’s type 2 diabetes drug, Trulicity (dulaglutide), has updated its label, discussing use in combination with basal insulin for adults with type 2 diabetes to achieve greater blood sugar control.

Meijer team members and their children will once again have a chance to receive up to $10,000 to further their college education with the Fred & Lena Meijer Scholarship program, a competitive scholarship administered by Grand Rapids Community Foundation.

A recently-published study in JAMA suggests that Clostridium difficile may be more effectively treated with vancomycin than its more commonly used counterpart metronidazole.

Securing a PGY1 requires pharmacy students to be prepared.

In 2016, novel medications approved by the FDA decreased from the encouraging tally of 45 that we saw last year to 22, the lowest it has been since 2010


The CDC has released its final 2017 updated adult vaccination recommendations approved by the Advisory Committee on Immunization Practices (ACIP).

Recreational drug use has been established as a risk factor for HIV acquisition, and many patients will find lifestyle modification—eschewing recreational drug use—difficult.

Diabesity is quickly transforming into a global health crisis that is no longer limited to developed countries.

Few health care innovations compare to vaccines in terms of reduced morbidity and mortality

Dispensing medication to patients can have many barriers. One of which can be language.

If you love a pharmacist, why not show them how much you care by getting them a creative, cool gift this Valentine’s Day?


The FDA recently accepted 2 new supplemental biologics license applications from Merck for pembrolizumab (Keytruda) in patients with bladder cancer.

Recently, pharmacy benefit managers (PBMs) have begun charging providers direct and indirect remuneration fees (DIR fees), which has resulted in many specialty pharmacies and physician-run practices closing their doors or increasing costs.